Aganepag is a potent Prostanoid EP2 receptor agonist, with an EC 50 of 0.19 nM, and shows no activity at EP4 receptor. Aganepag can be used in the research of wound healing, scar reduction, scar prevention and wrinkle treatment and prevention.
性状
Solid
IC50 & Target[1][2]
EC50: 0.19 nM (Prostanoid EP2 receptor)
体外研究(In Vitro)
Aganepag (Compound 3) is a potent Prostanoid EP2 receptor agonist, with an EC50 of 0.19 nM, and shows no activity at EP4. Aganepag can be used in the research of wound healing, scar reduction, scar prevention and wrinkle treatment and prevention. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Robert M. Burk, et al. Compounds and methods for skin repair. WO2014078434A1